Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

Inflammation, stress, and diabetes

Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · see citing works

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568 · see citing works

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · see citing works

Structure, mechanism and regulation of peroxiredoxins

Wood, Z. A., Schröder, E., Harris, J. R., & Poole, L. B. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00003-8 · Cited by 2,546 · see citing works

Reactive oxygen species have a causal role in multiple forms of insulin resistance

Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · see citing works

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,478 · see citing works

Biomarkers of Oxidative Damage in Human Disease

Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703 · see citing works

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,548 · see citing works

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

The Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216 · see citing works

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890 · see citing works

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 552 · see citing works

Risk models and scores for type 2 diabetes: systematic review

Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551 · see citing works

Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism

Ascaso, J. F., Pardo, S., Real, J. T., Lorente, R. I., Priego, A., & Carmena, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3320 · Cited by 490 · see citing works

Analysis of data from multiclinic trials

Fleiss, J. L. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90034-6 · Cited by 451 · see citing works

Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers

Giustarini, D., Dalle‐Donne, I., Tsikas, D., & Rossi, R. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408360903142326 · Cited by 443 · see citing works

Regulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation

Jin, D., Chae, H. Z., Rhee, S. G., & Jeang, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30952 · Cited by 412 · see citing works

Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study

Abbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321 · see citing works

Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality

Heerspink, H. J. L., Brantsma, A. H., de Zeeuw, D., Bakker, S. J. L., de Jong, P. E., Gansevoort, R. T., & for the PREVEND Study Group (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn209 · Cited by 253 · see citing works

Predicting Diabetes: Clinical, Biological, and Genetic Approaches

Balkau, B., Lange, C., Fezeu, L., Tichet, J., de Lauzon‐Guillain, B., Czernichow, S., Fumeron, F., Froguel, P., Vaxillaire, M., Cauchi, S., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0368 · Cited by 246 · see citing works

Peroxiredoxin IV Is a Secretable Protein with Heparin-Binding Properties under Reduced Conditions

Okado‐Matsumoto, A., Matsumoto, A., Fujii, J., & Taniguchi, N. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022632 · Cited by 182 · see citing works

Microalbuminuria and Risk of Venous Thromboembolism

Mahmoodi, B. K. (2009) · JAMA · doi:10.1001/jama.2009.565 · Cited by 177 · see citing works

Oxidative stress biomarkers as predictors of cardiovascular disease

Strobel, N., Fassett, R. G., Marsh, S. A., & Coombes, J. S. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.008 · Cited by 145 · see citing works

B- to Plasma-Cell Terminal Differentiation Entails Oxidative Stress and Profound Reshaping of the Antioxidant Responses

Bertolotti, M., Yim, S. H., García-Manteiga, J. M., Masciarelli, S., Kim, Y., Kang, M.-H., Iuchi, Y., Fujii, J., Venè, R., Rubartelli, A., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3079 · Cited by 125 · see citing works

Sulfiredoxin–Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling

Wei, Q., Jiang, H., Xiao, Z., Baker, A. R., Young, M. R., Veenstra, T. D., & Colburn, N. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013012108 · Cited by 111 · see citing works

Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model

Nabeshima, A., Yamada, S., Guo, X., Tanimoto, A., Wang, K., Shimajiri, S., Kimura, S., Tasaki, T., Noguchi, H., Kitada, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4946 · Cited by 104 · see citing works

Overexpression of Peroxiredoxin 4 Protects Against High-Dose Streptozotocin-Induced Diabetes by Suppressing Oxidative Stress and Cytokines in Transgenic Mice

Ding, Y., Yamada, S., Wang, K., Shimajiri, S., Guo, X., Tanimoto, A., Murata, Y., Kitajima, S., Watanabe, T., Izumi, H., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3137 · Cited by 91 · see citing works

Adjustment for Regression Dilution in Epidemiological Regression Analyses

Knuiman, M. W., Divitini, M., Buzas, J. S., & FitzGerald, P. E. B. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00107-5 · Cited by 83 · see citing works

Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome

Abbasi, A., Corpeleijn, E., Postmus, D., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0305 · Cited by 75 · see citing works

Characterization of Human and Mouse Peroxiredoxin IV: Evidence for Inhibition by Prx-IV of Epidermal Growth Factor- and p53-Induced Reactive Oxygen Species

Wong, C., Chun, A. C. S., Kok, K., et al. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192288 · Cited by 65 · see citing works

Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome

Dreja, T., Jovanovic, Z., Rasche, A., Kluge, R., Herwig, R., Tung, Y. C. L., Joost, H., Yeo, G. S. H., & Al‐Hasani, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1576-4 · Cited by 53 · see citing works

Circulating Levels of Peroxiredoxin 4 as a Novel Biomarker of Oxidative Stress in Patients with Sepsis

Schulte, J., Struck, J., Köhrle, J., & Müller, B. (2011) · Shock · doi:10.1097/shk.0b013e3182115f40 · Cited by 47 · see citing works

Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All‐Cause Mortality

Abbasi, A., Corpeleijn, E., Postmus, D., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., Struck, J., Schulte, J., Hillege, H. L., van der Harst, P., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002956 · Cited by 46 · see citing works

Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study

Hivert, M., SULLIVAN, L. M., Shrader, P. J., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., Kowall, B., Herder, C., Meisinger, C., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2067-y · Cited by 45 · see citing works

Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department

Nickel, C. H., Ruedinger, J. M., Misch, F., Blume, K., Maile, S., Schulte, J., Köhrle, J., Hartmann, O., Giersdorf, S., & Bingisser, R. M. (2011) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2011.01126.x · Cited by 43 · see citing works

The Association of Plasma Lactate With Incident Cardiovascular Outcomes

Matsushita, K., Williams, E., Mongraw‐Chaffin, M., Coresh, J., Schmidt, M. I., Brancati, F. L., Hoogeveen, R. C., Ballantyne, C. M., & Young, J. H. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt002 · Cited by 40 · see citing works

Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration

Schulte, J. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-137 · Cited by 40 · see citing works

Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent

Paynter, N. P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.351 · Cited by 38 · see citing works

Peroxiredoxin‐4 interacts with and regulates the thromboxane A2 receptor

Giguère, P. M., Turcotte, M.-E., Hamelin, É., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.011 · Cited by 38 · see citing works

Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease

Eter, E. A. E., Al‐Masri, A. A., Habib, S., Zamil, H. A., Hersi, A., Hussein, F. A., & Omran, M. A. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0442-y · Cited by 38 · see citing works

Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats

Barceló-Batllori, S., Corominola, H., Claret, M., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500050 · Cited by 36 · see citing works

Plasma procalcitonin and risk of type 2 diabetes in the general population

Abbasi, A., Corpeleijn, E., Postmus, D., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2216-3 · Cited by 35 · see citing works

Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum

Schulte, J., Struck, J., Bergmann, A., & Köhrle, J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.05.016 · Cited by 25 · see citing works

Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study

Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4 · see citing works

Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging

Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works

Relationship of Body Mass Index and Waist Circumference to Blood Pressure and Hypertension Prevalence in Employees in Shougang Shuicheng Iron and Steel Corporation

En-yun, H. (2011) · Practical Clinical Medicine

Waist Circumference as a Health Index and its Related Factors

Shibuya, M., Kamizato, M., & Tauchi, K. (2005) · SANGYO EISEIGAKU ZASSHI · doi:10.1539/sangyoeisei.47.122 · Cited by 2 · see citing works

Self-reported waist circumference compared with the ‘Waist Watcher’ tape-measure to identify individuals at increased health risk through intra-abdominal fat accumulation

Han, T. S., & Lean, M. E. J. (1998) · British Journal Of Nutrition · doi:10.1017/s0007114598001809 · Cited by 56 · see citing works

Change in waist circumference over 11 years and current waist circumference independently predict elevated CRP in Filipino women

Rutherford, J. N., McDade, T. W., Lee, N. R., Adair, L. S., & Kuzawa, C. W. (2009) · American Journal of Human Biology · doi:10.1002/ajhb.20986 · Cited by 12 · see citing works

Trends of abdominal obesity and waist circumference in premenopausal women

Rautio, E. K. (2015)